PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Laboratory of Stem Cell Regenerative Research, Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY, United States of America.\', \'Regeneron Genetics Center, Tarrytown, NY, United States of America.\', \'Imanis Life Sciences, Rochester, MN, United States of America.\', \'Vyriad, Inc., Rochester, MN, United States of America.\', \'Mayo Clinic Department of Molecular Medicine, Rochester, MN, United States of America.\', \'Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States of America.\', \'New York Blood Center Enterprises, New York, NY, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0250319
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33909646
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and \'Reopening\'.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33909646>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33909646>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all